Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Neoplasms
27. October 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 12326
Articles 1 - 20 / 246518
Hereditary Diffuse Gastric Cancer Syndrome.
Gastroenterol Clin North Am
Lerner BA, Llor X.
PMID: 42933935 [PubMed - indexed for MEDLINE]
Hamartomatous, Serrated, and Mixed Polyposis Syndromes.
Gastroenterol Clin North Am
Ebrahimzadeh JE, Zelley K, MacFarland SP, Katona BW.
PMID: 42933934 [PubMed - indexed for MEDLINE]
Updates in the Molecular Biology and Personalized Management of Lynch Syndrome.
Gastroenterol Clin North Am
Lee DJ, Yurgelun MB.
PMID: 42933932 [PubMed - indexed for MEDLINE]
A health-related quality of life measurement strategy for solid rare cancers: Primary findings from the EORTC Quality of Life Group (QLG) QoL Rare Cancer Study.
Eur J Cancer
Padilla CS, Bergerot CD, Bekta, Celik E, Robinson D, Bao Q, Burgers JA, Dejaco D, Fox L, Marquina G, Milanetto AC, Itkin B, Kindy AA, Lok C, di Monale E Bastia MB, Eichler M, Sodergren SC, Brouwer O, Ter Laan M, Tesselaar MET, van der Graaf WTA, Husson O, EORTC QoL Rare Cancer Study, EORTC Quality of Life Group.
PMID: 42933087 [PubMed - as supplied by publisher]
Identification of ceruloplasmin-binding anticancer peptides linked to cancer cell reprogramming in colorectal cancer.
Comput Biol Chem
Rehman A, Li T, Shaikh AL, Hassan SSU, Pan J.
PMID: 42933065 [PubMed - as supplied by publisher]
Survival modeling and assessing prognostic factors of colorectal cancer in Ethiopia: Addressing violation of statistical assumptions.
PLoS One
Abraha TG, Terefe MR, Asfaw ZG.
PMID: 42932349 [PubMed - indexed for MEDLINE]
Claudin-18 expression is associated with poorer overall survival in colorectal cancer.
PLoS One
Al-Kabariti AY, Abbas MA, Alashhab M, Smarakan S, Sughayer MA.
PMID: 42932274 [PubMed - indexed for MEDLINE]
Gut microbiome in colorectal cancer: a dual regulator of tumor biology and therapeutic response.
Folia Microbiol (Praha)
Chawda D, Tyagi N, Mubashra, Srivastava A, Shukla A, Srivastava S.
PMID: 42932086 [PubMed - as supplied by publisher]
Signal Mining of Adverse Events of Antiangiogenic Drugs in Colorectal Cancer Based on the FDA Adverse Event Reporting System (FAERS) Database.
J Gastrointest Cancer
Wu BX, Yu XN, Wu HT, Liu J.
PMID: 42932028 [PubMed - indexed for MEDLINE]
SLC25A39: A key regulator of mitochondrial metabolism and a promising therapeutic target in cancer.
Med Oncol
Tian T, Jin Y, Cui P, Lan S.
PMID: 42931978 [PubMed - indexed for MEDLINE]
Timing of diverting ileostomy closure after low anterior resection for rectal cancer: a GRADE-assessed systematic review and meta-analysis of early and delayed closure.
Langenbecks Arch Surg
Mirza W, Ullah SE, Babar M, Nand R, Hiraj UM, Soomro I, Saeed F, Ali RN.
PMID: 42931879 [PubMed - indexed for MEDLINE]
FGFR2b as a Therapeutic Biomarker in Gastric Cancer: Lessons from Bemarituzumab and Implications for Next-Generation Targeted Therapy.
Curr Oncol Rep
Sagawa T, Hirakawa M, Nagashima H, Fujikawa K.
PMID: 42931855 [PubMed - indexed for MEDLINE]
Cancer-associated fibroblasts and immune evasion in endometrial cancer: current evidence and therapeutic perspectives.
Med Oncol
Zhan J, Yan Z, Cao Z, Wu F, Wang Y, Zhan Y.
PMID: 42931843 [PubMed - indexed for MEDLINE]
Cancer Screening, Diagnosis, and Survival in California Prisons.
JAMA Netw Open
Manz CR, Tramontano AC, Voligny E, Dias SL, Dahlstrom M, Dunlap J, Johnson A, Rathore VD, Selby M, Sun RKP, Wright AA, Bick J.
PMID: 42931773 [PubMed - indexed for MEDLINE]
The Chemo-Gut Probiotic Trial Protocol: A Double-Blind Randomized Controlled Trial Investigating the Effects of a Multi-Strain Probiotic on Gut Microbiota, Gastrointestinal Symptoms, and Psychosocial Health Among Cancer Survivors.
Methods Protoc
Deleemans JM, Mina R, Spiropoulos A, Lawal OA, Reimer RA, Karim S, Richardson B, Carlson LE.
PMID: 42931362 [PubMed]
Advanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI b2000 and b1000.
J Pers Med
Lee G, Kim SH, Kim M, Kim D, Kim HR.
PMID: 42930811 [PubMed]
VEGF-A Immunohistochemical Expression Across Appendiceal Epithelial Lesions: A Retrospective Exploratory Study.
Med Sci (Basel)
Tavra A, , , Lozi, Ogorevc M, Krstulovi, Hrgovi, Kre, Bar.
PMID: 42930603 [PubMed - indexed for MEDLINE]
Association Between Low Anterior Resection Syndrome and Lower Urinary Tract Symptom Severity After Restorative Rectal Cancer Surgery.
Med Sci (Basel)
Lunca S, Morarasu S, Roata CE, Dimofte GM.
PMID: 42930601 [PubMed - indexed for MEDLINE]
From Dysbiosis to Symbiosis: Using the Gut Microbiome to Improve Cancer Outcomes.
Med Sci (Basel)
Nassar SA.
PMID: 42930589 [PubMed - indexed for MEDLINE]
Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe.
Med Sci (Basel)
Filip AM, Munteanu SN, Mocan S, Chiciudean PL, Arjoca L, Pantea CM, Filip MI, Negovan A.
PMID: 42930580 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 246518
Page 1 of 12326
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy